Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy

被引:10
作者
Hemal, AK [1 ]
Khaitan, A [1 ]
Dinda, AK [1 ]
Gupta, NP [1 ]
Seth, A [1 ]
Dogra, PN [1 ]
Nabi, G [1 ]
机构
[1] All India Inst Med Sci, Dept Urol, New Delhi 110029, India
关键词
p53; transitional cell carcinoma; urinary bladder; invasive; cystectomy; bladder tumour;
D O I
10.1159/000067703
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The objective of the study was to determine the pattern of p53 expression in patients with muscle invasive bladder cancer treated with cystectomy and to assess the prognostic value of p53 expression in this group of patients. Materials and Methods: We retrospectively analyzed data of 100 patients who underwent cystectomy for invasive transitional cell carcinoma of the urinary bladder. These patients were seen at 3-monthly intervals during the first 2 years, 6-monthly in the third year, and yearly thereafter. Immunohistochemical analysis for p53 was done on paraffin-fixed tissues with DO-7 antibodies. The tumours with >30% cells staining for p53 proteins were considered p53 positive. Results: There were 95 males and 5 females with a mean age of 54 years. Two patients died in the perioperative period and were excluded from analysis. Over a median follow-up period of 2 years (range 3 months to 10 years) 62 patients are alive without disease while 36 had relapse and of these, 31 have died. The p53 expression was significantly related to stage and grade of the tumour. p53-negative tumours were more likely to be organ confined and of lower grade as compared to p53-positive tumours. The stage of tumour was significantly related to outcome but grade and p53 immunohistochemistry did not provide any prognostic information. Conclusions: p53 immunostaining was positive in 57% of muscle invasive urinary bladder tumours. The p53 positivity correlated well with the stage and grade of the disease, whereas it has no additional prognostic value. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 25 条
[1]   P53 MUTATIONS IN HUMAN BLADDER-CANCER - GENOTYPIC VERSUS PHENOTYPIC PATTERNS [J].
CORDONCARDO, C ;
DALBAGNI, G ;
SAEZ, GT ;
OLIVA, MR ;
ZHANG, ZF ;
ROSAI, J ;
REUTER, VE ;
PELLICER, A .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) :347-353
[2]   ACCUMULATION OF NUCLEAR P53 AND TUMOR PROGRESSION IN BLADDER-CANCER [J].
ESRIG, D ;
ELMAJIAN, D ;
GROSHEN, S ;
FREEMAN, JA ;
STEIN, JP ;
CHEN, SC ;
NICHOLS, PW ;
SKINNER, DG ;
JONES, PA ;
COTE, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) :1259-1264
[3]  
ESRIG D, 1993, AM J PATHOL, V143, P1390
[4]   Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder [J].
Glick, SH ;
Howell, LP ;
White, RWD .
JOURNAL OF UROLOGY, 1996, 155 (05) :1754-1757
[5]   Apoptosis: Molecular regulation of cell death [J].
Hale, AJ ;
Smith, CA ;
Sutherland, LC ;
Stoneman, VEA ;
Longthorne, VL ;
Culhane, AC ;
Williams, GT .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (01) :1-26
[6]   P53 IN TUMOR PATHOLOGY - CAN WE TRUST IMMUNOHISTOCHEMISTRY - REVISITED [J].
HALL, PA ;
LANE, DP .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :1-4
[7]  
HERMANEK P, 1987, TNM CLASSIFICATION U
[8]  
JOHANSON S, 1996, J UROLOGY, V160, P1291
[9]   Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas [J].
Kakehi, Y ;
Özdemir, E ;
Habuchi, T ;
Yamabe, H ;
Hashimura, H ;
Katsura, Y ;
Yoshida, O .
JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (02) :214-220
[10]   p53 overexpression as a prognostic factor for advanced stage bladder cancer [J].
Kuczyk, MA ;
Bokemeyer, C ;
Serth, J ;
Hervatin, C ;
Oelke, M ;
Hofner, K ;
Tan, HK ;
Jonas, U .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) :2243-2247